INSIGHTS ON CELL & GENE OUTSOURCING ISSUES
-
Overcoming 3 Key Challenges Facing Life Science Contract Manufacturers
Explore the key challenges faced by CMOs and CDMOs in the life sciences industry and how digital transformation can help overcome them.
-
3 Things To Look For In A Pharma Contract Manufacturing Partner
Discover three key steps you can follow to streamline the selection process and identify the CMOs best suited to help your organization achieve its goals, quickly bring products to market, and more.
-
Cell & Gene Therapy Testing
Cell and Gene Therapies hold immense potential for revolutionizing healthcare. However, ensuring the safety and efficacy of these therapies is paramount. Learn how the right partner can empower you to unlock the full potential of your CGT.
-
4 Critical CMO/CDMO Capabilities: Navigating The Evolving Contract Manufacturing Landscape
This comprehensive guide equips contract manufacturers with the tools to thrive in the ever-evolving life sciences industry. Read how to streamline and optimize your contract manufacturing operations.
-
Ensure A Seamless Handover Stage In The Technology Transfer Process
Understanding the key elements in the handover stage of a technology transfer is critical to your success. This is an overview of the Handover Stage of PDA TR-65.
-
Clinical Research Solutions
A global team of trusted experts for multi-phase clinical development.
-
Qualified Person (QP) Services
Providing around-the-clock support, enabled by at least two QPs per assignment, delivering full continuity, and reduced risk.
-
Streamline The Path From Discovery To Patient: Simpler RNA Manufacturing
Review the benefits of a co-transcriptional capping RNA polymerase engineered to produce synthetic RNA to meet these increasing demands for safety and cost-effectiveness.
-
Great siRNA Science Or Savvy Business Acumen? You Need Both
Silence Therapeutics has two wholly owned siRNA therapies now in clinical trials and one partnered program with AstraZeneca. Silence's CEO discusses the need for good science, making smart business decisions, and cultivating partnerships.
-
Improve Bioprocess Freezing Outcomes With Analytics And Testing Services
While AI is an exciting area for the biopharmaceutical sector, other shorter-term and more tangible things can be done to get life-saving medicines to market faster.